KFDA Focuses on Biotechnology Based Biopharmaceuticals
Published: 2004-12-31 06:56:00
Updated: 2004-12-31 06:56:00
The Korea Food and Drug Administration (KFDA) recently released the next year's plans on improving the administrative efforts dealing with biotechnology-based biopharmaceutical products, to further strengthen overall safety and quality measures.
Key Biopharmaceutical Initiatives:
(a) Impro...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
